Live Breaking News & Updates on Genitourinary cancers program

Stay informed with the latest breaking news from Genitourinary cancers program on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Genitourinary cancers program and stay connected to the pulse of your community

Dr Grivas on Frontline Treatment Options in Metastatic RCC

Petros Grivas, MD, PhD, discusses frontline treatment options for patients with metastatic renal cell carcinoma.

Petros-grivas , Scott-tykodi , University-of-washington-uw-school-medicine , Fred-hutchinson-cancer-center , Clinical-research-division , Division-of-hematology , Genitourinary-cancers-program , Science-summit , D , Hd , Patients-with-metastatic-renal-cell-carcinoma ,

Grivas Expands on Key Data From the 2023 ESMO Congress in Urothelial Cancer

Petros Grivas, MD, PhD, spotlights key advancements and research in urothelial cancer reported at the 2023 ESMO Congress, detailing findings from the phase 3 CheckMate 901, EV-302/KEYNOTE-A39, and THOR trials.

Petros-grivas , University-of-washington-school-medicine , Genitourinary-cancers-program , Clinical-research-division-at-fred-hutch , Division-of-medical-oncology , Science-summit , Medical-oncology , Washington-school , Clinical-research-division , Fred-hutch , Fred-hutch-cancer-center , Urothelial-cancer

Grivas Expands on Therapeutic Developments and Future Research Directions in GU Cancers

Petros Grivas, MD, PhD, discusses the role of single-agent and combination PARP inhibitor regimens in prostate cancer, as well as the importance of genetic testing in this setting, the role of adjuvant regimens in resected renal cell carcinoma, and more.

University-of-washington , Washington , United-states , Seattle , Evan-hall , Petros-grivas , Michael-schweizer , Lisa-tachiki , Scott-tykodi , Clinical-research-division-at-fred-hutch , Genitourinary-cancers-program , Division-of-medical-oncology

Dr Grivas on Key Data From the CheckMate 901 Trial in Urothelial Cancer

Petros Grivas, MD, PhD, discusses outcomes associated with the phase 3 CheckMate 901 trial in metastatic or unresectable urothelial carcinoma, highlighting the importance of these data.

Petros-grivas , Genitourinary-cancers-program , Clinical-research-division , Seattle-cancer-care-alliance , University-of-washington-uw-school-medicine , Fred-hutchinson-cancer-research-center , Division-of-medical-oncology , Medical-oncology , Metastatic-or-unresectable-urothelial-carcinoma , Phase-3-checkmate-901-trial-nct03036098- , Nivolumab-opdivo- ,

Dr Grivas on Addressing Unmet Needs in Urothelial Cancer

Petros Grivas, MD, PhD, discusses several unmet needs within urothelial cancer, as well as how to potentially ameliorate them.

Petros-grivas , Fred-hutchinson-cancer-research-center , Genitourinary-cancers-program , Seattle-cancer-care-alliance , Division-of-medical-oncology , Clinical-research-division , University-of-washington-uw-school-medicine , Medical-oncology , Fred-hutch-cancer-center , Onclive-tv , Urothelial-cancer , Unmet-needs

Dr Grivas on Sacituzumab Govitecan Plus Pembrolizumab in Metastatic Urothelial Cancer

Petros Grivas, MD, PhD, discusses findings from the primary analysis of cohort 3 of the phase 2 TROPHY U-01 trial in patients with metastatic urothelial cancer.

Petros-grivas , Genitourinary-cancers-program , Division-of-oncology , Department-of-medicine , University-of-washington-school-medicine , Clinical-research-division , Fred-hutch-cancer-center , University-of-washington-medicine , Washington-medicine , Washington-school , D , Hd

3 Ways to Empower Yourself After an Advanced Bladder Cancer Diagnosis (Ad)

Three tips prepare after an advanced bladder cancer diagnosis; access trusted resources, take an active role in helping to develop a treatment plan, and identify an advocate.

United-states , American , Petros-grivas , Fred-hutchinson-cancer-center , University-of-washington , American-cancer-society , Genitourinary-cancers-program , Active-role , Clinical-director ,